Skip to content
OpenCapital
Get started

Eli Lilly LLY UNITED STATES And PUERTO RICO — Non-Current Assets

Other geography segments

Rest of world
$3.52B+62.9%

Similar metrics at other companies

Bausch + Lomb logo
BLCOU.S. and Puerto Rico — Long-Lived Assets
$836M+4.8%
AbbVie logo
ABBVUnited States And Puerto Rico — Total long-lived assets
$3.4B+2.2%
Torrid Holdings logo
CURVPUERTO RICO — Long-Lived Assets
$0—
Transocean logo
RIGUS — Non-Current Assets
$6.49B-3.6%
Clarus Corporation logo
CLARUS — Non-Current Assets
$14.7M-15.1%
Mesa Laboratories logo
MLABUS — Non-Current Assets
$29.89M+2.4%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.09T+56.4%
Enterprise value$1.12T+53.8%
P/E42.9×-7.3×
P/S15×+2.0×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Eli Lilly’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's united states and puerto rico — non-current assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's UNITED STATES and PUERTO RICO — non-current assets?
Eli Lilly (LLY) reported UNITED STATES and PUERTO RICO — non-current assets of $18.76B in Q4 2025.
How has Eli Lilly's UNITED STATES and PUERTO RICO — non-current assets changed year-over-year?
Eli Lilly's UNITED STATES and PUERTO RICO — non-current assets increased by 40.0% year-over-year, from $13.4B to $18.76B.
What does UNITED STATES and PUERTO RICO — non-current assets mean?
This metric represents the total value of long-term assets, such as property, plant, equipment, and intangible assets, attributed to the United States and Puerto Rico geographic segment. It reflects the capital investment and infrastructure footprint required to support the company's primary research, manufacturing, and commercial operations within this core market. Monitoring this balance helps investors assess the scale of regional operations and the long-term capital commitment to the domestic pharmaceutical market.